跳到主要內容

臺灣博碩士論文加值系統

(3.237.38.244) 您好!臺灣時間:2021/07/24 17:16
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:張淑杏
研究生(外文):Shu-Shing Chang
論文名稱:口腔鱗狀細胞癌中離胺基氧化酶的表現和調控
論文名稱(外文):The Expression and Regulation of Lysyl Oxidase in Oral Squamous Cell Carcinoma
指導教授:林姝君林姝君引用關係
指導教授(外文):Shu-Chun Lin
學位類別:碩士
校院名稱:國立陽明大學
系所名稱:口腔生物研究所
學門:醫藥衛生學門
學類:牙醫學類
論文種類:學術論文
論文出版年:2004
畢業學年度:92
語文別:中文
論文頁數:81
中文關鍵詞:檳榔子水萃取物離胺基氧化酶口腔鱗狀細胞癌非癌配對組織
外文關鍵詞:areca nut extract (ANE)lysyl oxidase (LOX)oral squamous cell carcinoma (OSCC)non-cancer matched tissue (NCMT)
相關次數:
  • 被引用被引用:0
  • 點閱點閱:86
  • 評分評分:
  • 下載下載:8
  • 收藏至我的研究室書目清單書目收藏:0
根據流行病學資料顯示,在台灣口腔癌於男性前十大癌症發生率中高居第四位,死亡率則為所有癌症之第七位,其原因與嚼食檳榔有密切關係。檳榔子水萃取物 (ANE) 為檳榔嚼塊之主要成分,且對於多種型態細胞具有細胞毒性以及基因毒性。目前對檳榔誘發口腔細胞轉型之基因調控機制瞭解不多。本實驗室先前利用刪減雜合術 (subtractive hybridization library) 篩選出口腔鱗狀細胞癌表現異常之基因,其中lysyl oxidase (LOX) 於口腔鱗狀細胞癌之表現大增。LOX是一個與銅離子依存的胺氧化酶,能夠在細胞外基質 (extracellular matrix,ECM),藉由氧化膠原蛋白和彈性蛋白上特殊的離胺酸殘基,使膠原蛋白和彈性蛋白交叉共價鍵結,並與腫瘤生成有關。但LOX和LOX類似蛋白質近年亦發現具抑癌功能,且LOX基因家族在口腔癌生成之角色至今仍具爭議性。
實驗首先就LOX基因在正常口腔角質上皮細胞 (normal human oral keratinocyte, NHOK) 及不同口腔癌細胞株中mRNA的表現作比較,發現LOX和LOXL3在不同口腔癌細胞株中的表現皆比正常口腔角質上皮細胞增加許多。在37組口腔鱗狀細胞癌與非癌配對組織中,探討LOX家族成員mRNA 表現之差異,結果LOX、LOXL2、LOXL3 mRNA 在口腔鱗狀細胞癌表現大於非癌配對組織,且LOXL3 mRNA表現上升與患者之較低存活率有關。以檳榔子水萃取物處理正常口腔角質上皮細胞和口腔鱗狀細胞癌細胞株OEC-M1,發現隨著劑量之升高,LOX mRNA表現也隨之提升,但非透過檳榔素 (檳榔主要成份之一) 之調控。此外,以RNAi技術建立刪減 (knock-down) LOX之穩定細胞株,方便以後對於LOX與細胞的外型、增生、細胞週期、貼附能力、藥劑的敏感度等進一步觀察。綜合以上本研究之發現, LOX及其家族基因在口腔癌所中扮演應屬促癌之角色。
Epidemiological studies showed that the incidence of oral cancer is the 4th most common cancer in males and the 7th highest cause for cancer death in Taiwan. Areca nut extract (ANE), the main component of AQ, exerts cytotoxicity and genotoxicity to several types of cells. The pathogenetic mechanism for the transformation of oral keratinocyte is not clear today. Previous studies from our laboratory used the subtractive hybridization library technique to identify differentially expressed genes in oral squamous cell carcinoma (OSCC) and non-cancer matched tissue (NCMT). And identified several representative genes overexpressed in OSCC including lysyl oxidase (LOX). LOX is a copper-dependent amine oxidase that initiates the covalent cross-linking of collagen and elastin in extracellular matrix, and involved in tumorigenesis. However, LOX and LOX-related (LOXL) superfamily members have also been advocated as a tumor suppressor recently. In addition, the role of LOX in OSCC seemed controversial.
First, this study examined the expression of LOX in normal human oral keratinocyte (NHOK) and OSCC cell lines. The result showed a significant increase of LOX and LOXL3 gene expression in different cancer cells comparing to NHOK. Comparsion between OSCC/NCMT pairs from 37 patients showed that LOX 、LOXL2 and LOXL3 mRNA expression were increased significantly in OSCC relative to NCMT, and the increase of LOXL3 mRNA expression correlated with lower survival rate of patients. In NHOK and an OSCC cell line, OEC-M1 treated with ANE, LOX mRNA expression was increased dose-dependently. But a major areca ingredient, arecoline did not cause such increase. LOX siRNA stable OSCC cells were established. This knock-down cells will be used to perceive the role of LOX in proliferation, invasion, mobility, anti-senescence, anti-apoptosis and
chemoresistance of OSCC cells in vitro. In conclusion, the findings in the present study substantiate that LOX gene families play an oncogenic role in OSCC.
1.Ranasinghe, A. W., Warnakulasuriya, K. A. and Johnson, N.
W. Low prevalence of expression of p53 oncoprotein in
oral carcinomas from Sri-Lanka associated with betel and
tobacco chewing. Eur J Cancer B Oral Oncol, 29: 147-150,
1993.
2.Chen, G. S. and Chen, C. H. A statistical analysis of
oral squamous cell carcinoma. Gaoxiong Yi Xue Ke Xue Za
Zhi, 11: 582-588., 1995.
3.Chen, Y. K., Huang, H. C., Lin, L. M., and Lin, C. C.
Primary oral squamous cell carcinoma: an analysis of 703
cases in southern Taiwan. Oral Oncol, 35: 173-179., 1999.
4.Marshall, J. R., Graham, S., Haughey, B. P., Shedd, D.,
O''Shea, R., Brasure, J., Wilkinson, G. S., and West, D.
Smoking, alcohol, dentition and diet in the epidemiology
of oral cancer. Eur J Cancer B Oral Oncol, 28B: 9-15,
1992.
5.Mashberg, A., Boffetta, P., Winkelman, R., and Garfinkel,
L. Tobacco smoking, alcohol drinking, and cancer of the
oral cavity and oropharynx among U.S. veterans. Cancer,
72: 1369-1375, 1993.
6.Pillai, R., Reddiar, K. S., and Balaram, P. Oncogene
expression and oral cancer. J Surg Oncol, 47: 102-108,
1991.
7.Ponder, B. A. Genetic predisposition to cancer. Br J
Cancer, 64: 203-204, 1991.
8.Hollstein, M., Sidransky, D., Vogelstein, B., and Harris,
C. C. p53 mutations in human cancers. Science, 253: 49-
53, 1991.
9.Smith, C. A., Smith, G. and Wolf , C. R. Genetic
polymorphisms in xenobiotic metabolism. Eur J Cancer, 30:
1921-1935, 1994.
10.Sharma, D. C. Betel quid and areca nut are carcinogenic
without tobacco. Lancet Oncol, 4: 587, 2003.
11.Zain, R. B. Cultural and dietary risk factors of oral
cancer and precancer--a brief overview. Oral Oncology,
37: 205-210, 2001.
12.Ko, Y. C., Huang, Y. L., Lee, C. H., Chen, M. J., Lin,
L. M., and Tsai, C. C. Betel quid chewing, cigarette
smoking and alcohol consumption related to oral cancer
in Taiwan. J Oral Pathol Med, 24: 450-453., 1995.
13.Lu, C. T., Yen, Y. Y., Ho, C. S., Ko, Y. C., Tsai, C.
C., Hsieh, C. C., and Lan, S. J. A case-control study of
oral cancer in Changhua County, Taiwan. J Oral Pathol
Med, 25: 245-248., 1996.
14.吳成文 , 賴美淑, 姚克明 , 余惠君 檳榔嚼塊的化學致癌性暨其
防治 : 現況與未來. 台北財團法人國家衛生研究院 p3-7, 22-
23.
15.IARC Monographs on the Evalution of Carcinogenesis Risk
of Chemicals to Humans. 37, Lyon, IARC, 1985.
16.Shirname, L. P., Menon, M. M., Nair, J., and Bhide, S.
V. Correlation of mutagenicity and tumorigenicity of
betel quid and its ingredients. Nutr Cancer, 5: 87-91,
1983.
17.Lin, L. M., Chen, Y. K., Lai, D. R., Huang, Y. L., and
Chen, H. R. Cancer-promoting effect of Taiwan betel quid
in hamster buccal pouch carcinogenesis. Oral Diseases,
3: 232-235, 1997.
18.Jin, Y. T., Tsai, S. T., Wong, T. Y., Chen, F. F., and
Chen, R. M. Studies on promoting activity of Taiwan
betel quid ingredients in hamster buccal pouch
carcinogenesis. Eur J Cancer B Oral Oncol, 32B: 343-
346., 1996.
19.Fang, C., Liu, S., Sheng, Z., Li, Z., and Tang, F. Study
on the cytotoxic and DNA damaging effects in oral
mucosal fibroblasts by areca nut extract. Hunan Yi Ke Da
Xue Xue Bao, 22: 105-108, 1997.
20.Dave, B. J., Trivedi, A. H., and Adhvaryu, S. G. In
vitro genotoxic effects of areca nut extract and
arecoline. J Cancer Res Clin Oncol, 118: 283-288, 1992.
21.Sundqvist, K., Liu, Y., Nair, J., Bartsch, H., Arvidson,
K., and Grafstrom, R. C. Cytotoxic and genotoxic effects
of areca nut-related compounds in cultured human buccal
epithelial cells. Cancer Res, 49: 5294-5298., 1989.
22.Sundqvist, K. and Grafstrom, R. C. Effects of areca nut
on growth, differentiation and formation of DNA damage
in cultured human buccal epithelial cells. Int J Cancer,
52: 305-310., 1992.
23.Nair, U. J., Obe, G., Friesen, M., Goldberg, M. T., and
Bartsch, H. Role of lime in the generation of reactive
oxygen species from betel- quid ingredients. Environ
Health Perspect, 98: 203-205., 1992.
24.Friesen, M., Maru, G., Bussachini, V., Bartsch, H.,
Nair, U., Nair, J., and Floyd, R. A. Formation of
reactive oxygen species and of 8-hydroxy-2''-
deoxyguanosine in DNA in vitro with betel-quid
ingredients. IARC Sci Publ, 89: 417-421, 1988.
25.Nair, U. J., Floyd, R. A., Nair, J., Bussachini, V.,
Friesen, M., and Bartsch, H. Formation of reactive
oxygen species and of 8-hydroxydeoxyguanosine in DNA in
vitro with betel quid ingredients. Chem Biol Interact,
63: 157-169, 1987.
26.Chen, C. L., Chi, C. W., and Liu, T. Y. Hydroxyl radical
formation and oxidative DNA damage induced by areca quid
in vivo. J Toxicol Environ Health A, 65: 327-336., 2002.
27.Liu, T. Y., Chen, C. L., and Chi, C. W. Oxidative damage
to DNA induced by areca nut extract. Mutat Res, 367: 25-
31., 1996.
28.Trackman, P. C., Pratt, A. M., Wolanski, A., Tang, S.
S., Offner, G. D., Troxler, R. F., and Kagan, H. M.
Cloning of rat aorta lysyl oxidase cDNA: complete codons
and predicted amino acid sequence. Biochemistry, 30:
8282, 1991.
29.Kagan, H. M., Vaccaro, C. A., Bronson, R. E., Tang, S.
S., and Brody, J. S. Ultrastructural immunolocalization
of lysyl oxidase in vascular connective tissue. J Cell
Biol, 103: 1121-1128, 1986.
30.Smith-Mungo, L. I. and Kagan, H. M. Lysyl oxidase:
properties, regulation and multiple functions in
biology. Matrix Biol, 16: 387-398, 1998.
31.Cao, T. Available at :
http://lmp.biomed.hawaii.edu/programs/lysyl_oxidase/index.html.
32.Wang, S. X., Mure, M., Medzihradszky, K. F., Burlingame,
A. L., Brown, D. E., Dooley, D. M., Smith, A. J., Kagan,
H. M., and Klinman, J. P. A crosslinked cofactor in
lysyl oxidase: redox function for amino acid side
chains. Science, 273: 1078-1084, 1996.
33.Kenyon, K., Contente, S., Trackman, P. C., Tang, J.,
Kagan, H. M., and Friedman, R. M. Lysyl oxidase and rrg
messenger RNA. Science, 253: 802, 1991.
34.Kirschmann, D. A., Seftor, E. A., Fong, S. F., Nieva, D.
R., Sullivan, C. M., Edwards, E. M., Sommer, P.,
Csiszar, K., and Hendrix, M. J. A molecular role for
lysyl oxidase in breast cancer invasion. Cancer Res, 62:
4478-4483, 2002.
35.Peyrol, S., Galateau-Salle, F., Raccurt, M., Gleyzal,
C., and Sommer, P. Selective expression of lysyl oxidase
(LOX) in the stromal reactions of broncho-pulmonary
carcinomas. Histol Histopathol, 15: 1127-1135, 2000.
36.Stassar, M. J., Devitt, G., Brosius, M., Rinnab, L.,
Prang, J., Schradin, T., Simon, J., Petersen, S., Kopp-
Schneider, A., and Zoller, M. Identification of human
renal cell carcinoma associated genes by suppression
subtractive hybridization. Br J Cancer, 85: 1372-1382,
2001.
37.Trivedy, C., Warnakulasuriya, K. A., Hazarey, V. K.,
Tavassoli, M., Sommer, P., and Johnson, N. W. The
upregulation of lysyl oxidase in oral submucous fibrosis
and squamous cell carcinoma. J Oral Pathol Med, 28: 246-
251, 1999.
38.Ma, R. H., Tsai, C. C., and Shieh, T. Y. Increased lysyl
oxidase activity in fibroblasts cultured from oral
submucous fibrosis associated with betel nut chewing in
Taiwan. J Oral Pathol Med, 24: 407-412, 1995.
39.He, J., Tang, H. J., Wang, Y. Y., Xiong, M. H., Zhou,
F., Shao, K., and Li, T. P. [Expression of lysyl oxidase
gene in upper digestive tract carcinomas and its
clinical significance]. Ai Zheng, 21: 671-674, 2002.
40.Rost, T., Pyritz, V., Rathcke, I. O., Gorogh, T., Dunne,
A. A., and Werner, J. A. Reduction of LOX- and LOXL2-
mRNA expression in head and neck squamous cell
carcinomas. Anticancer Res, 23: 1565-1573, 2003.
41.Holtmeier, C., Gorogh, T., Beier, U., Meyer, J.,
Hoffmann, M., Gottschlich, S., Heidorn, K., Ambrosch,
P., and Maune, S. Overexpression of a novel lysyl
oxidase-like gene in human head and neck squamous cell
carcinomas. Anticancer Res, 23: 2585-2591, 2003.
42.Lazarus, H. M., Cruikshank, W. W., Narasimhan, N.,
Kagan, H. M., and Center, D. M. Induction of human
monocyte motility by lysyl oxidase. Matrix Biol, 14: 727-
731, 1995.
43.Li, W., Liu, G., Chou, I. N., and Kagan, H. M. Hydrogen
peroxide-mediated, lysyl oxidase-dependent chemotaxis of
vascular smooth muscle cells. J Cell Biochem, 78: 550-
557, 2000.
44.Li, W., Nellaiappan, K., Strassmaier, T., Graham, L.,
Thomas, K. M., and Kagan, H. M. Localization and
activity of lysyl oxidase within nuclei of fibrogenic
cells. Proc Natl Acad Sci U S A, 94: 12817-12822, 1997.
45.Mello, M. L., Contente, S., Vidal, B. C., Planding, W.,
and Schenck, U. Modulation of ras transformation
affecting chromatin supraorganization as assessed by
image analysis. Exp Cell Res, 220: 374-382, 1995.
46.Giampuzzi, M., Botti, G., Cilli, M., Gusmano, R., Borel,
A., Sommer, P., and Di Donato, A. Down-regulation of
lysyl oxidase-induced tumorigenic transformation in NRK-
49F cells characterized by constitutive activation of
ras proto-oncogene. J Biol Chem, 276: 29226-29232, 2001.
47.Butler, E., Hardin, J., and Benson, S. The role of lysyl
oxidase and collagen crosslinking during sea urchin
development. Exp Cell Res, 173: 174-182, 1987.
48.Csiszar, K., Entersz, I., Trackman, P. C., Samid, D.,
and Boyd, C. D. Functional analysis of the promoter and
first intron of the human lysyl oxidase gene. Mol Biol
Rep, 23: 97-108, 1996.
49.Di Donato, A., Lacal, J. C., Di Duca, M., Giampuzzi, M.,
Ghiggeri, G., and Gusmano, R. Micro-injection of
recombinant lysyl oxidase blocks oncogenic p21-Ha-Ras
and progesterone effects on Xenopus laevis oocyte
maturation. FEBS Lett, 419: 63-68, 1997.
50.Ren, C., Yang, G., Timme, T. L., Wheeler, T. M., and
Thompson, T. C. Reduced lysyl oxidase messenger RNA
levels in experimental and human prostate cancer. Cancer
Res, 58: 1285-1290, 1998.
51.Hajnal, A., Klemenz, R., and Schafer, R. Up-regulation
of lysyl oxidase in spontaneous revertants of H-ras-
transformed rat fibroblasts. Cancer Res, 53: 4670-4675,
1993.
52.Oberhuber, H., Seliger, B., and Schafer, R. Partial
restoration of pre-transformation levels of lysyl
oxidase and transin mRNAs in phenotypic ras revertants.
Mol Carcinog, 12: 198-204, 1995.
53.Hamalainen, E. R., Kemppainen, R., Kuivaniemi, H.,
Tromp, G., Vaheri, A., Pihlajaniemi, T., and Kivirikko,
K. I. Quantitative polymerase chain reaction of lysyl
oxidase mRNA in malignantly transformed human cell lines
demonstrates that their low lysyl oxidase activity is
due to low quantities of its mRNA and low levels of
transcription of the respective gene. J Biol Chem, 270:
21590-21593, 1995.
54.Meng, C. L., Tu, L. C., Chang, L. C., Hsu, S. F., and
Wu, C. H. Establishment and characterization of a human
oral epidermoid carcinoma cell line. Molecular biology
of neoplasia(Academia sinica, Taipei) 374-376, 1985.
55.Lin, S. C., Liu, C. J., Chiu, C. P., Chang, S. M., Lu,
S. Y., and Chen, Y. J. Establishment of OC3 oral
carcinoma cell line and identification of NF-kappa B
activation responses to areca nut extract. J Oral Pathol
Med, 33: 79-86, 2004.
56.Rheinwald, J. G. and Beckett, M. A. Tumorigenic
keratinocyte lines requiring anchorage and fibroblast
support cultures from human squamous cell carcinomas.
Cancer Res, 41: 1657-1663, 1981.
57.Okumura, K., Konishi, A., Tanaka, M., Kanazawa, M.,
Kogawa, K., and Niitsu, Y. Establishment of high- and
low-invasion clones derived for a human tongue squamous-
cell carcinoma cell line SAS. J Cancer Res Clin Oncol,
122: 243-248, 1996.
58.Zamore, P. D. RNA interference:listening to the sound of
silence. nature structural biology, 8: 746-750, 2001.
59.Paul, C. P., Good, P. D., Winer, I., and Engelke, D. R.
Effective expression of small interfering RNA in human
cells. Nat Biotechnol, 20: 505-508, 2002.
60.Brummelkamp, T. R., Bernards, R., and Agami, R. A system
for stable expression of short interfering RNAs in
mammalian cells. Science, 296: 550-553, 2002.
61.Shi, Y. Mammalian RNAi for the masses. Trends Genet, 19:
9-12, 2003.
62.呂思逸 檳榔子水萃取物對人類口腔上皮細胞表型及相關抑癌基因
活化影響之探討. 台北: 國立陽明大學, 2002.
63.Jeng, J. H., Wang, Y. J., Chiang, B. L., Lee, P. H.,
Chan, C. P., Ho, Y. S., Wang, T. M., Lee, J. J., Hahn,
L. J., and Chang, M. C. Roles of keratinocyte
inflammation in oral cancer: regulating the
prostaglandin E2, interleukin-6 and TNF-alpha production
of oral epithelial cells by areca nut extract and
arecoline. Carcinogenesis, 24: 1301-1315, 2003.
64.李思穎 檳榔嚼塊成分對口腔上皮細胞轉錄因子NF-kB活性之調
控. 台北: 國立陽明大學, 2003.
65.Saito, H., Papaconstantinou, J., Sato, H., and
Goldstein, S. Regulation of a novel gene encoding a
lysyl oxidase-related protein in cellular adhesion and
senescence. J Biol Chem, 272: 8157-8160, 1997.
66.Wei, Y. Y. a. C., C. Elemental analysis of Taiwanese
areca nut and limes with INAA. J. Radioanal. Nucl. Ch.,
217: 45-51, 1997.
67.Lin, J. K. and Liang, Y. C. Cancer chemoprevention by
tea polyphenols. Proc Natl Sci Counc Repub China B, 24:
1-13, 2000.
68.Palamakumbura, A. H. and Trackman, P. C. A fluorometric
assay for detection of lysyl oxidase enzyme activity in
biological samples. Anal Biochem, 300: 245-251, 2002.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關論文
 
1. 4. 丁道源,〈從刑事政策談更生保護制度〉,《警專學報》第2卷第4期,1998年4月,1-13頁。
2. 9. 周震歐,〈我國更生保護事業之展望〉,《犯罪學期刊》第3期,1997年12月,1-11頁。
3. 7. 李清泉,〈受刑人再社會化之意義及受其影響後之徵狀〉,《法務通訊》第1916期,1999年1月28日,6版。
4. 10. 房麗雲,〈司法保護三區結合計畫之我見〉,《法務通訊》第1881期,1998年5月28日,3版。
5. 6. 朱鎮明,〈新公共管理的政治哲學基礎研究〉,《中國行政評論》第9卷第3期,2000年6月,53-72頁。
6. 5. 王方,〈反省與突破:社會福利政策之重新思考〉,《立法院院聞》第28卷第11期,2000年11月,18-45頁。
7. 3. 丁道源,〈更生保護制度之回顧與展望〉,《警專學報》第2卷第3期,1997年6月,75-91頁。
8. 11. 洪惠芬,〈對依賴者的道德責任:另一種詮釋『福利依賴』的觀點〉,《人文及社會科學集刊》第14卷第3期,2002年9月,409-464頁。
9. 12. 郭靜晃、胡中宜,〈更生保護與青少年庇護制度〉,《社區發展季刊》第79期,1997年9月,235-249頁。
10. 15. 黃永斌,〈最好的更生保護政策,就是最好的預防再犯政策〉,《法務通訊》第1997期,2000年8月31日,3-6版。
11. 16. 黃偉峰,〈左派、右派、或是第三條路?英國主要政黨意識型態之區隔,1979-1997〉,《理論與政策》第61期,2002年3月,1-25頁。
12. 17. 黃榮堅,〈重刑化刑事政策之商榷〉,《臺灣本土法學雜誌》第45期,2003年4月,66-75頁。
13. 18. 黃翠紋,〈犯罪抗制策略的新典範——復歸性正義模式的社區參與〉,《社區發展季刊》第82期,1998年6月,58-69頁。
14. 19. 詹火生,〈劇變時代的社會福利政策〉,《國家政策論壇》第1卷第10期,2001年12月,171-177頁。
15. 20. 趙麗雲,〈更生保護工作不能好大喜央r,《國家政策論壇》第1卷第8期,2001年10月,162-163頁。